BrainsWay Selected to Participate in FDA Innovation Challenge: Devices to Prevent and Treat Opioid Use Disorder

BrainsWay Selected to Participate in FDA Innovation Challenge: Devices to Prevent and Treat Opioid Use Disorder 12/10/2018 HACKENSACK, N.J., Dec. 10, 2018 (GLOBE NEWSWIRE) — BrainsWay Ltd. (BRIN.TA), the parent company of BrainsWay USA, Inc., and a global leader in the advanced non-invasive treatment of brain disorders, today announces that the Company’s deep transcranial magnetic…

Achieve TMS East Expands to Chelmsford

By Alana Melanson, amelanson@lowellsun.com UPDATED:   12/09/2018 09:27:26 AM EST   CHELMSFORD — One in six Americans will experience a depressive episode at some point in life, and for a third of them, medication and therapy won’t offer significant relief, according to Dr. Rebecca Knapp. For that subset with treatment-resistant depression, Achieve TMS East offers…

Deep Dive – Achieve TMS East Is Changing the Lives of People with Depression

By JOSEPH BEDNAR September 2018 Margie Pierce understands the difficulty — and, yet, the importance — of tackling the problem of depression. “It’s the leading cause of disability worldwide right now,” said Pierce, a licensed clinical social worker and director of operations at Achieve TMS East, a fast-growing chain of behavioral-health practices that employ an…

ACHIEVE TMS EAST TO PROVIDE GROUNDBREAKING FDA APPROVED TREATMENT FOR OBSESSIVE COMPULSIVE DISORDER

NORTHAMPTON, MASSACHUSETTS,- Achieve TMS East, Massachusett’s leading provider of Deep Transcranial Magnetic Stimulation (dTMS), is pleased to announce that Brainsway, which manufacturers dTMS technologies for the treatment of brain disorders, has received approval from the US Food and Drug Administration (FDA) for its non-invasive device in the treatment of obsessive-compulsive disorder (OCD).  FDA approval of…